Delivery Cas9 into mitochondria
- Авторлар: Orishchenko K.E1,2, Sofronova J.K2, Chupakhin E.G2, Lunev E.A2, Mazunin I.O2
-
Мекемелер:
- Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences
- Kant Baltic Federal University
- Шығарылым: Том 11, № 2 (2016)
- Беттер: 100-105
- Бөлім: Articles
- ##submission.dateSubmitted##: 05.01.2023
- ##submission.datePublished##: 15.06.2016
- URL: https://genescells.ru/2313-1829/article/view/120599
- DOI: https://doi.org/10.23868/gc120599
- ID: 120599
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
K. Orishchenko
Federal Research Center Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences; Kant Baltic Federal University
Email: OrishchenkoKE@icg.sbras.ru
Novosibirsk, Russia; Kaliningrad, Russia
J. Sofronova
Kant Baltic Federal UniversityKaliningrad, Russia
E. Chupakhin
Kant Baltic Federal UniversityKaliningrad, Russia
E. Lunev
Kant Baltic Federal UniversityKaliningrad, Russia
I. Mazunin
Kant Baltic Federal UniversityKaliningrad, Russia
Әдебиет тізімі
- Schaefer A.M., McFarland R., Blakely E.L. et al. Prevalence of mitochondrial DNA disease in adults. Ann. Neurol. 2008; 63: 35-9.
- DiMauro S., Schon E.A., Carelli V. et al. The clinical maze of mitochondrial neurology. Nat. Rev. Neurol. 2013; 9: 429-44.
- Schon E.A., DiMauro S., Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 2012; 13: 878-90.
- Sander J.D., Joung J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 2014; 32: 347-55.
- Harrison M.M., Jenkins B.V., 0'Connor-Giles K.M. et al. CRISPR view of development. Genes Dev. 2014; 28: 1859-72.
- Gammage P.A., Rorbach J., Vincent A.I. et al. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMB0 Mol. Med. 2014; 6: 458-66.
- Bacman S.R., Williams S.L., Pinto M. et al. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat. Med. 2013; 19: 1111-3.
- Yang L., Guell M., Byrne S. et al. 0ptimization of scarless human stem cell genome editing. Nucleic Acids Res. 2013; 41: 9049-61.
- Sieber F., Duchene A.M., Marechal-Drouard L. Mitochondrial RNA import: from diversity of natural mechanisms to potential applications. Int. Rev. Cell Mol. Biol. 2011; 287: 145-90.
- Mali P., Yang L., Esvelt K.M. et al. RNA-guided human genome engineering via Cas9. Science 2013; 339: 823-6.
- Kaltimbacher V., Bonnet C., Lecoeuvre G. et al. mRNA localization to the mitochondrial surface allows the efficient translocation inside the organelle of a nuclear recoded ATP6 protein. RNA 2006; 12: 1408-17.
- Neupert W., Herrmann J.M. Translocation of proteins into mitochondria. Annu. Rev. Biochem. 2007; 76: 723-49.
- Fink M., Flekna G., Ludwig A. et al. Improved translation efficiency of injected mRNA during early embryonic development. Dev. Dyn. 2006; 235: 3370-8.
- Wang G., Chen H.W., 0ktay Y. et al. PNPASE regulates RNA import into mitochondria. Cell 2010; 142: 456-67.
- Wang G., Shimada E., Koehler C.M. et al. PNPASE and RNA trafficking into mitochondria. Biochim. Biophys. Acta 2012; 1819: 998-1007.
- Tonin Y., Heckel A.M., Dovydenko I. et al. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA. Biochimie 2014; 100: 192-9.
- Tonin Y., Heckel A.M., Vysokikh M. et al. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA. J. Biol. Chem. 2014; 289: 13323-34.
- Ran F.A., Cong L., Yan W.X. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 2015; 520: 186-91.
- Zetsche B., Gootenberg J.S., Abudayyeh O.O. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 2015; 163: 759-71.
- Shmakov S., Abudayyeh O.O., Makarova K.S. et al. Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems. Moll. Cell 2015; 60: 385-97.
- Jo A., Ham S., Lee G.H. et al. Efficient Mitochondrial Genome Editing by CRISPR/Cas9. Biomed. Res. Int. 2015; 2015: 305716.
- Ran F.A., Hsu P.D., Wright J. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013; 8: 2281-308.